skip to main content

Chemistry, part 1

زبان محتوا

پشتیبانی: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > ceramide > ganglioside > sialotriaosylceramide > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-acetylneuraminyl-(2->8)-alpha-n-acetylneuraminyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1)-ceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > ceramide > ganglioside > sialotriaosylceramide > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-acetylneuraminyl-(2->8)-alpha-n-acetylneuraminyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1)-ceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > organooxygen compound > sphingolipid > ceramide > ganglioside > sialotriaosylceramide > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-acetylneuraminyl-(2->8)-alpha-n-acetylneuraminyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1)-ceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > ceramide > ganglioside > sialotriaosylceramide > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-acetylneuraminyl-(2->8)-alpha-n-acetylneuraminyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1)-ceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > organooxygen compound > carboxamide > ceramide > ganglioside > sialotriaosylceramide > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-acetylneuraminyl-(2->8)-alpha-n-acetylneuraminyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1)-ceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > ceramide > ganglioside > sialotriaosylceramide > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-acetylneuraminyl-(2->8)-alpha-n-acetylneuraminyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1)-ceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > liposaccharide > glycolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialotriaosylceramide > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-acetylneuraminyl-(2->8)-alpha-n-acetylneuraminyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1)-ceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialotriaosylceramide > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-acetylneuraminyl-(2->8)-alpha-n-acetylneuraminyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1)-ceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialotriaosylceramide > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-acetylneuraminyl-(2->8)-alpha-n-acetylneuraminyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1)-ceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialotriaosylceramide > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-acetylneuraminyl-(2->8)-alpha-n-acetylneuraminyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1)-ceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > organooxygen compound > sphingolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialotriaosylceramide > n-acetyl-beta-d-galactosaminyl-(1->4)-[alpha-n-acetylneuraminyl-(2->8)-alpha-n-acetylneuraminyl-(2->3)]-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1)-ceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > ceramide > ganglioside > sialotriaosylceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > ceramide > ganglioside > sialotriaosylceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > organooxygen compound > sphingolipid > ceramide > ganglioside > sialotriaosylceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > ceramide > ganglioside > sialotriaosylceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > organooxygen compound > carboxamide > ceramide > ganglioside > sialotriaosylceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > ceramide > ganglioside > sialotriaosylceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > liposaccharide > glycolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialotriaosylceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialotriaosylceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialotriaosylceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialotriaosylceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer
... > organooxygen compound > sphingolipid > glycosphingolipid > acidic glycosphingolipid > ganglioside > sialotriaosylceramide > beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer

اصطلاح مرجح

beta-d-galnac-(1->4)-[alpha-neu5ac-(2->8)-alpha-neu5ac-(2->3)]-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer  

نوع

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

مفهوم اعم

مفهوم‌های اخص

شناسه-آلت

  • CHEBI:21178
  • CHEBI:5210
  • CHEBI:5247

بار

  • 0

فرمول

  • C61H103N4O34R

بخشی دارد

نقشی دارد

اسید-مزدوج-است

جرم

  • 1436.47690

جرم تک‌ایزوتوپی

  • 1435.64537

اسمایلٓ

  • [H][C@]1(O[C@@](C[C@H](O)[C@H]1NC(C)=O)(O[C@H](CO)[C@@H](O)[C@]1([H])O[C@@](C[C@H](O)[C@H]1NC(C)=O)(O[C@@H]1[C@@H](O)[C@@H](O[C@H](CO)[C@@H]1O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1NC(C)=O)O[C@H]1[C@H](O)[C@@H](O)[C@H](OC[C@H](NC([*])=O)[C@H](O)/C=C/CCCCCCCCCCCCC)O[C@@H]1CO)C(O)=O)C(O)=O)[C@H](O)[C@H](O)CO

زیرمجموعه

  • 3_STAR

مترادف دقیق

  • (2S,3R,4E)-2-(acylamino)-3-hydroxyoctadec-4-en-1-yl 2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1->4)-[5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->8)-5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl]-(2->3)-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranoside

مترادف مرتبط

  • beta-GalpNAc-(1->4)-[alpha-Neu5Ac-(2->8)-alpha-Neu5Ac-(2->3)]-beta-Galp-(1->4)-beta-Glcp-(1<->1')-Cer
  • disialoganglioside GD2
  • (Gal)1 (GalNAc)1 (Glc)1 (Neu5Ac)2 (Cer)1
  • GalNAc-beta1->4(NeuAc-alpha2->8NeuAc2->3)Gal-beta1->4Glc-beta1->1'Cer
  • GalNAc-beta1->4(NeuAc-alpha2->8NeuAc2->3)LacCer
  • GalNAc(beta1-4)[NeuAc(alpha2-8)NeuAc(alpha2-3)]Gal(beta1-4)Glc(beta1-1)Cer
  • GalNAcbeta1-4(NeuAcalpha2-8NeuAcalpha2-3)Galbeta1-4Glcbeta1-1'Cer
  • GalNAcbeta1->4(NeuAcalpha2->8NeuAcalpha2->3)Galbeta1->4Glc-Cer
  • ganglioside GD2
  • GD2

در زبان های دیگر

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:28648

این مفهوم را بارگیری کن:

RDF/XML TURTLE JSON-LD